» Authors » Prisca Bustamante

Prisca Bustamante

Explore the profile of Prisca Bustamante including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 131
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopez R, Ben El Khyat C, Chen Y, Tsering T, Dickinson K, Bustamante P, et al.
Sci Rep . 2025 Mar; 15(1):8430. PMID: 40069225
Extracellular vesicles (EVs) are secreted by most cell types and play a central role in cell-cell communication. These naturally occurring nanoparticles have been particularly implicated in cancer, but EV heterogeneity...
2.
Bustamante P, Coblentz J, Mastromonaco C, Youhnovska E, Ito H, Proenca R, et al.
Melanoma Res . 2024 Jun; 34(4):285-295. PMID: 38847739
Uveal melanoma is the most common intraocular tumor in adults. Our group has previously developed a human uveal melanoma animal model; however, adverse effects caused by the immunosuppressive agent, cyclosporine...
3.
Goyeneche A, Lasiste J, Abdouh M, Bustamante P, Burnier J, Burnier Jr M
Cancer Cell Int . 2024 May; 24(1):180. PMID: 38783299
Background: Although rare, uveal melanoma (UM) is a life-threatening malignancy. Understanding its biology is necessary to improve disease outcome. Three-dimensional (3D) in vitro culture methods have emerged as tools that...
4.
Tsering T, Li M, Chen Y, Nadeau A, Laskaris A, Abdouh M, et al.
J Extracell Vesicles . 2022 Oct; 11(10):e12270. PMID: 36271888
Extracellular vesicles (EVs) play a key role in cellular communication both in physiological conditions and in pathologies such as cancer. Emerging evidence has shown that EVs are active carriers of...
5.
Subeha M, Goyeneche A, Bustamante P, Lisio M, Burnier J, Telleria C
Cancers (Basel) . 2022 Jan; 14(1). PMID: 35008264
High-grade serous ovarian cancer (HGSOC) is a significant cause of mortality among women worldwide. Traditional treatment consists of platinum-based therapy; however, rapid development of platinum resistance contributes to lower life...
6.
Bustamante P, Tsering T, Coblentz J, Mastromonaco C, Abdouh M, Fonseca C, et al.
J Exp Clin Cancer Res . 2021 Jun; 40(1):196. PMID: 34134723
Background: Uveal melanoma (UM) is the most common intraocular tumor in adults. Despite good primary tumor control, up to 50% of patients develop metastasis, which is lethal. UM often presents...
7.
Tsering T, Laskaris A, Abdouh M, Bustamante P, Parent S, Jin E, et al.
Cancers (Basel) . 2020 Oct; 12(10). PMID: 33050649
Extracellular vesicles (EVs) carry molecules derived from donor cells and are able to alter the properties of recipient cells. They are important players during the genesis and progression of tumors....
8.
Bustamante P, Piquet L, Landreville S, Burnier J
Semin Cancer Biol . 2020 May; 71:65-85. PMID: 32450140
Uveal melanoma (UM) is a type of intraocular tumor with a propensity to disseminate to the liver. Despite the identification of the early driver mutations during the development of the...
9.
Bustamante P, Miyamoto D, Goyeneche A, Garcia de Alba Graue P, Jin E, Tsering T, et al.
Cancer Med . 2019 Oct; 8(17):7265-7277. PMID: 31588689
Background: Melanoma is a life-threatening group of cancers mainly affecting the skin (cutaneous melanoma, CM) and the eyes (uveal melanoma, UM). Nearly half of patients with UM develop liver metastases...
10.
Chavira-Suarez E, Sandoval A, Quintero H, Bustamante P, Felix R, Lamas M
Biochem Biophys Res Commun . 2012 Jan; 418(2):420-5. PMID: 22277672
Hyperglycemia alters the tight control of intracellular calcium dynamics in retinal cells and may lead to the development of diabetic retinopathy. The potassium channel interacting protein 3 (KChIP3) also known...